» Articles » PMID: 36015310

Practical Considerations for Translating Mesenchymal Stromal Cell-Derived Extracellular Vesicles from Bench to Bed

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2022 Aug 26
PMID 36015310
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular vesicles (EVs) derived from mesenchymal stromal cells (MSCs) have shown potential for the treatment of tendon and ligament injuries. This approach can eliminate the need to transplant live cells to the human body, thereby reducing issues related to the maintenance of cell viability and stability and potential erroneous differentiation of transplanted cells to bone or tumor. Despite these advantages, there are practical issues that need to be considered for successful clinical application of MSC-EV-based products in the treatment of tendon and ligament injuries. This review aims to discuss the general and tissue-specific considerations for manufacturing MSC-EVs for clinical translation. Specifically, we will discuss Good Manufacturing Practice (GMP)-compliant manufacturing and quality control (parent cell source, culture conditions, concentration method, quantity, identity, purity and impurities, sterility, potency, reproducibility, storage and formulation), as well as safety and efficacy issues. Special considerations for applying MSC-EVs, such as their compatibility with arthroscopy for the treatment of tendon and ligament injuries, are also highlighted.

Citing Articles

GelMA encapsulating BMSCs-exosomes combined with interference screw or suture anchor promotes tendon-bone healing in a rabbit model.

Gao M, Zhao P, Xing J, Wang Z, Xu Y, Yan Y Sci Rep. 2024; 14(1):28212.

PMID: 39548341 PMC: 11568266. DOI: 10.1038/s41598-024-79787-0.


Can miRNAs in MSCs-EVs Offer a Potential Treatment for Hypoxic-ischemic Encephalopathy?.

Al-Ward H, Chen W, Gao W, Zhang C, Yang X, Xiong Y Stem Cell Rev Rep. 2024; 21(1):236-253.

PMID: 39503828 DOI: 10.1007/s12015-024-10803-6.


Optimizing mesenchymal stem cell extracellular vesicles for chronic wound healing: Bioengineering, standardization, and safety.

Shimizu Y, Ntege E, Inoue Y, Matsuura N, Sunami H, Sowa Y Regen Ther. 2024; 26:260-274.

PMID: 38978963 PMC: 11228664. DOI: 10.1016/j.reth.2024.06.001.


Extracellular vesicles from dental pulp mesenchymal stem cells modulate macrophage phenotype during acute and chronic cardiac inflammation in athymic nude rats with myocardial infarction.

Amaro-Prellezo E, Gomez-Ferrer M, Hakobyan L, Ontoria-Oviedo I, Peiro-Molina E, Tarazona S Inflamm Regen. 2024; 44(1):25.

PMID: 38807194 PMC: 11134765. DOI: 10.1186/s41232-024-00340-7.


Mesenchymal stromal cell-derived extracellular vesicles therapy openings new translational challenges in immunomodulating acute liver inflammation.

Sitbon A, Delmotte P, Pistorio V, Halter S, Gallet J, Gautheron J J Transl Med. 2024; 22(1):480.

PMID: 38773651 PMC: 11106935. DOI: 10.1186/s12967-024-05282-9.


References
1.
Yu H, Cheng J, Shi W, Ren B, Zhao F, Shi Y . Bone marrow mesenchymal stem cell-derived exosomes promote tendon regeneration by facilitating the proliferation and migration of endogenous tendon stem/progenitor cells. Acta Biomater. 2020; 106:328-341. DOI: 10.1016/j.actbio.2020.01.051. View

2.
Zhu Y, Shi M, Monsel A, Dai C, Dong X, Shen H . Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study. Stem Cell Res Ther. 2022; 13(1):220. PMC: 9135389. DOI: 10.1186/s13287-022-02900-5. View

3.
Mendt M, Kamerkar S, Sugimoto H, McAndrews K, Wu C, Gagea M . Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight. 2018; 3(8). PMC: 5931131. DOI: 10.1172/jci.insight.99263. View

4.
Skog J, Wurdinger T, van Rijn S, Meijer D, Gainche L, Sena-Esteves M . Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10(12):1470-6. PMC: 3423894. DOI: 10.1038/ncb1800. View

5.
Collino F, Pomatto M, Bruno S, Lindoso R, Tapparo M, Sicheng W . Exosome and Microvesicle-Enriched Fractions Isolated from Mesenchymal Stem Cells by Gradient Separation Showed Different Molecular Signatures and Functions on Renal Tubular Epithelial Cells. Stem Cell Rev Rep. 2017; 13(2):226-243. PMC: 5380712. DOI: 10.1007/s12015-016-9713-1. View